# K090894: Collawound Wound Dressing

- Pathway: 510(k) (Traditional)
- Applicant: Collamatrix Co., Inc.
- Decided: Jun 25, 2009 after 86 days
- Product code: KGN (Wound Dressing With Animal-Derived Material(S))
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K921895 (1992). 36 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 39 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K061474: Collawound Dressing, Collamatrix Co., Inc. (2006) Summary page 2.
- K021792: Bilayer Matrix Wound Dressing, Integra Lifesciences Corp. (2002) Summary page 2.
- K022127: Avagen Wound Dressing, Integra Lifesciences Corp. (2002) Summary page 2.
- K993948: Sis Wound Dressing II, Cook Biotech, Inc. (2000) Summary page 2.

## Most influential descendants
- K162348: ABCcolla Collagen Matrix (2017), 1 descendant of its own
- K233378: ABCcolla® Collagen ADM Scaffold (2024), 0 descendants of its own

## Indications for use
CollaWound wound dressing is intended for the management of wounds including: - partial and full-thickness wounds - 'diabetic ulcers - venous ulcers - pressure ulcers - chronic vascular ulcers - tunneled/undermined wounds surgical wounds (donor site/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence) trauma wounds (abrasions, lacerations, secondary-degree bums, and skin tears) - draining wounds

Source page: https://510kreport.com/device/K090894
Methodology: https://510kreport.com/methodology